or
forgot password
  • cancer clinical trials in houston, TX

  • Docetaxel With or Without Oblimersen in Treating Patients With Non-Small Cell Lung Cancer
    University of Texas - MD Anderson Cancer Center
    Houston, Texas 77030-4009
    Lung Cancer
    Research Study of Visilizumab for Treatment of Glucocorticoid- Refractory Graft Versus Host Disease
    Baylor College of Medicine

    Trial Locations
    Baylor College of Medicine
    MD Anderson Cancer Center
    Graft-vs-Host Disease
    Study of Hyper-CVAD Plus Imatinib Mesylate for Philadelphia-Positive Acute Lymphocytic Leukemia
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Leukemia, Lymphocytic, Acute, L2
    Therapy of Early Chronic Phase CML With Higher-Dose Gleevec, Alpha Interferon, and Low-Dose Ara-C
    M.D. Anderson Cancer Center
    Houston, Texas 77030
    Myelogenous Leukemia, Chronic, Chronic Phase
    Therapy of HES, PV, Atypical CML or CMML, and Mastocytosis With Imatinib Mesylate
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Chronic Myelomonocytic Leukemia, Chronic Myeloid Leukemia, Polycythemia Vera, Hypereosinophilic Syndrome, Mastocytosis
    Clinical Trial to Screen Participants Who Are at High Genetic Risk for Ovarian Cancer
    M. D. Anderson Cancer Center at University of Texas
    Houston, Texas 77030-4009
    Ovarian Cancer
    Effectiveness and Safety of INGN 201 in Combination With Chemotherapy Versus Chemotherapy Alone
    University of Texas, MD Andersen Cancer Center
    Houston, Texas 77030
    Carcinoma, Squamous Cell
    Visilizumab in Treating Patients With Graft-Versus-Host Disease Following Donor Stem Cell Transplantation
    Baylor College of Medicine

    Trial Locations
    Baylor College of Medicine
    University of Texas - MD Anderson Cancer Center
    Graft Versus Host Disease
    A Phase II Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Rebif® in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis
    Baylor College of Medicine, Dept. of Neurology
    Houston, Texas
    Multiple Sclerosis, Relapsing-Remitting
    Vaccine Therapy for Patients With Stage III Melanoma
    University of Texas - MD Anderson Cancer Center
    Houston, Texas 77030-4009
    Malignant Melanoma
    Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
    University of Texas - MD Anderson Cancer Center
    Houston, Texas 77030-4009
    Lymphoma
    Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
    Baylor College of Medicine

    Trial Locations
    Baylor College of Medicine
    M D Anderson Cancer Center
    Childhood Embryonal Tumor, Childhood Extracranial Germ Cell Tumor, Childhood Extragonadal Germ Cell Tumor, Childhood Malignant Ovarian Germ Cell Tumor, Childhood Malignant Testicular Germ Cell Tumor, Childhood Teratoma, Ovarian Embryonal Carcinoma, Ovarian Yolk Sac Tumor, Stage II Malignant Testicular Germ Cell Tumor, Stage IIA Ovarian Germ Cell Tumor, Stage IIB Ovarian Germ Cell Tumor, Stage IIC Ovarian Germ Cell Tumor, Stage III Malignant Testicular Germ Cell Tumor, Stage IIIA Ovarian Germ Cell Tumor, Stage IIIB Ovarian Germ Cell Tumor, Stage IIIC Ovarian Germ Cell Tumor, Testicular Choriocarcinoma and Yolk Sac Tumor, Testicular Embryonal Carcinoma
    Study of High-Dose Pulse Administration DN-101 (Calcitriol) in Patients With Myelodysplastic Syndrome (MDS)
    University of Texas - MD Anderson Cancer Center
    Houston, Texas 77030-4009
    Myelodysplastic Syndrome
    Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma
    M.D. Anderson Cancer Center at University of Texas
    Houston, Texas 77030
    Brain and Central Nervous System Tumors
    Administration of Epstein Barr Virus (EBV) Specific Cytotoxic T-Cells, ANGEL
    Baylor College of Medicine

    Trial Locations
    Baylor College of Medicine
    Texas Children's Hospital
    The Methodist Hospital
    Epstein-Barr Virus-Related Hodgkin Lymphoma, Epstein-Barr Virus-Related Non-Hodgkin Lymphoma, EBV Positive Plasma Cell Neoplasm
    Stem Cell Transplant for Hematologic Diseases
    Texas Children's Hospital

    Trial Locations
    Texas Children's Hospital
    The Methodist Hospital
    Hematologic Malignancies
    LMP-specific T-cells for Patients With Relapsed EBV-positive Lymphoma
    Baylor College of Medicine

    Trial Locations
    Baylor College of Medicine
    Texas Children's Hospital
    The Methodist Hospital
    Hodgkin Disease, Non Hodgkin Lymphoma
    Randomized Double Cord Blood Transplant Study
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Leukemia, Lymphocytic, Acute, Leukemia, Myelocytic, Acute, Leukemia, Myeloid, Chronic, Lymphoma, Non-Hodgkin
    Alopecia Areata Registry
    M.D. Anderson Cancer Center
    Houston, Texas 77030
    Alopecia Areata, Alopecia Totalis, Alopecia Universalis, Autoimmune Hair Loss, Alopecia Partialis
    Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
    Baylor University Medical Center - Houston

    Trial Locations
    Baylor University Medical Center - Houston
    M. D. Anderson Cancer Center at University of Texas
    Leukemia
    Stem Cell Transplantation in Individuals With Multiple Myeloma
    Baylor College of Medicine/The Methodist Hospital

    Trial Locations
    Baylor College of Medicine/The Methodist Hospital
    University of Texas/MD Anderson Cancer Research Center
    Multiple Myeloma
    Cytotoxic T-Lymphocytes for the Prophylaxis of Cytomegalovirus After Allogeneic Stem Cell Transplant
    The Methodist Hospital
    Houston, Texas 77030
    Cytomegalovirus Infections
    Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
    Veterans Affairs Medical Center - Houston

    Trial Locations
    Veterans Affairs Medical Center - Houston
    Baylor University Medical Center - Houston
    Ben Taub General Hospital
    St. Luke's Texas Cancer Institute at St. Luke's Episcopal Hospital
    Metastatic Cancer, Prostate Cancer
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Methodist Hospital

    Trial Locations
    Methodist Hospital
    Veterans Administration Medical Center
    Saint Luke's Episcopal Hospital
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    LMP2a-Specific Cytotoxic T-Lymphocytes Following CD45 Antibody for Lymphoma
    Baylor College of Medicine

    Trial Locations
    Baylor College of Medicine
    Texas Children's Hospital
    The Methodist Hospital
    Lymphoma
    Short-Term Low-Dose Interferon Alfa in Treating Patients With Cancer of the Urothelium
    M. D. Anderson Cancer Center at University of Texas
    Houston, Texas 77030-4009
    Bladder Cancer, Urethral Cancer
    Study of Late-Occurring Complications in Childhood Cancer Survivors
    Baylor College of Medicine
    Houston, Texas 77030
    Cancer Survivor, Cardiovascular Complications, Hematopoietic/Lymphoid Cancer, Unspecified Childhood Solid Tumor, Protocol Specific